These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
217 related items for PubMed ID: 14742799
1. Decreased phenobarbital absorption with charcoal administration for chronic renal failure. Tanaka C, Yagi H, Sakamoto M, Koyama Y, Ohmura T, Ohtani H, Sawada Y. Ann Pharmacother; 2004 Jan; 38(1):73-6. PubMed ID: 14742799 [Abstract] [Full Text] [Related]
2. Acceleration of the body clearance of phenobarbital by oral activated charcoal. Berg MJ, Berlinger WG, Goldberg MJ, Spector R, Johnson GF. N Engl J Med; 1982 Sep 09; 307(11):642-4. PubMed ID: 7050705 [Abstract] [Full Text] [Related]
3. Combination of oral activated charcoal plus low protein diet as a new alternative for handling in the old end-stage renal disease patients. Musso CG, Michelangelo H, Reynaldi J, Martinez B, Vidal F, Quevedo M, Parot M, Waisman G, Algranati L. Saudi J Kidney Dis Transpl; 2010 Jan 09; 21(1):102-4. PubMed ID: 20061701 [Abstract] [Full Text] [Related]
4. Factors influencing the clinical efficacy of activated charcoal. Watson WA. Drug Intell Clin Pharm; 1987 Feb 09; 21(2):160-6. PubMed ID: 3549212 [Abstract] [Full Text] [Related]
6. Effects of food type on the extent of drug-drug interactions between activated charcoal and phenobarbital in rats. Ogata Y, Imaoka A, Akiyoshi T, Ohtani H. Drug Metab Pharmacokinet; 2019 Aug 09; 34(4):287-291. PubMed ID: 31255507 [Abstract] [Full Text] [Related]
7. Effect of activated charcoal administration on acetylcysteine serum levels in humans. North DS, Peterson RG, Krenzelok EP. Am J Hosp Pharm; 1981 Jul 09; 38(7):1022-4. PubMed ID: 7258201 [Abstract] [Full Text] [Related]
8. Use of activated charcoal to reduce elevated serum phenobarbital concentration in a neonate. Veerman M, Espejo MG, Christopher MA, Knight M. J Toxicol Clin Toxicol; 1991 Jul 09; 29(1):53-8. PubMed ID: 2005666 [Abstract] [Full Text] [Related]
9. Accelerated clearance of intravenously administered theophylline and phenobarbital by oral doses of activated charcoal in rats. A possibility of the intestinal dialysis. Arimori K, Nakano M. J Pharmacobiodyn; 1986 May 09; 9(5):437-41. PubMed ID: 3761133 [Abstract] [Full Text] [Related]
10. Kinetics of drug action in disease states. XXXIX. Effect of orally administered activated charcoal on the hypnotic activity of phenobarbital and the neurotoxicity of theophylline administered intravenously to rats with renal failure. Hoffman A, Levy G. Pharm Res; 1990 Mar 09; 7(3):242-6. PubMed ID: 2339096 [Abstract] [Full Text] [Related]
11. Treatment of phenobarbitone poisoning with repeated oral administration of activated charcoal. Boldy DA, Vale JA, Prescott LF. Q J Med; 1986 Nov 09; 61(235):997-1002. PubMed ID: 3659250 [Abstract] [Full Text] [Related]
13. Effects of orally administered activated charcoal on ciprofloxacin pharmacokinetics in healthy volunteers. Torre D, Sampietro C, Quadrelli C, Bianchi W, Maggiolo F. Chemioterapia; 1988 Dec 09; 7(6):382-6. PubMed ID: 3219749 [Abstract] [Full Text] [Related]
14. Effect of activated charcoal on rifampicin absorption in man. Orisakwe OE, Dioka CE, Okpogba AN, Orish CN, Ofoefule SI. Tokai J Exp Clin Med; 1996 Feb 09; 21(1):51-4. PubMed ID: 9239805 [Abstract] [Full Text] [Related]
15. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis. Brandi L. Dan Med Bull; 2008 Nov 09; 55(4):186-210. PubMed ID: 19232159 [Abstract] [Full Text] [Related]
16. Interaction of carbamazepine and phenobarbital in rabbits. Rukhadze MD, Alexishvili MM, Okujava NV, Sebiskveradze MV, Okujava VM, Tsagareli SK. Biomed Chromatogr; 2000 Aug 09; 14(5):344-8. PubMed ID: 10960836 [Abstract] [Full Text] [Related]